tubocurarine has been researched along with huperzine a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badia, A; Baños, JE; Barril, X; Camps, P; Luque, FJ; Morral, J; Muñoz-Torrero, D; Orozco, M; Vivas, NM | 1 |
1 other study(ies) available for tubocurarine and huperzine a
Article | Year |
---|---|
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Bridged Bicyclo Compounds; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Humans; In Vitro Techniques; Male; Mice; Models, Molecular; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Neuroprotective Agents; Quinolines; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Tacrine; Tubocurarine | 2000 |